Skip to main content
Natural Capsules Ltd. logo

Natural Capsules Ltd. — Investor Relations & Filings

Ticker · NATCAPSUQ ISIN · INE936B01015 LEI · 335800JVYFZWBNKMS446 BSE.NS Manufacturing
Open in API
Filings indexed 86 across all filing types
Latest filing 2025-09-30 Board/Management Inform…
Country IN India
Listing BSE.NS NATCAPSUQ

About Natural Capsules Ltd.

https://www.naturalcapsules.com

Natural Capsules Ltd. is a specialized manufacturer of hard capsules catering to the pharmaceutical and nutraceutical sectors. The company produces a wide range of products, including hard gelatin capsules and vegetarian alternatives such as HPMC (Hydroxypropyl Methylcellulose) capsules. Its manufacturing capabilities extend to specialized variants like liquid-fill capsules and preservative-free options. The company emphasizes adherence to international quality standards and Good Manufacturing Practices (GMP) to ensure product safety and efficacy. By leveraging advanced technology in capsule shell production, it serves a global clientele of pharmaceutical formulators and dietary supplement providers. The core focus remains on providing high-quality delivery systems for oral dosage forms, supporting diverse therapeutic and nutritional applications.

Recent filings

Filing Released Lang Actions
Retirement
Board/Management Information Classification · 100% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) regarding the retirement of a senior management personnel, specifically the Chief Operating Officer, Mr. MVN Kutty. It references compliance with SEBI Listing Regulations, particularly Regulation 30 related to disclosure of events or information. The content is about management change disclosure, not a financial report, audit, or earnings release. The document length is short (3188 characters) and it is an announcement of a management change event. Therefore, it fits the category of Board/Management Information (MANG).
2025-09-30 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notification addressed to stock exchanges about the closure of the trading window for insiders ahead of the announcement of quarterly financial results. It references SEBI regulations on insider trading and specifies the trading window closure period around the upcoming financial results for the quarter ended September 30, 2025. The document does not contain any financial data or results itself, nor does it present a report or detailed financial analysis. It is a regulatory announcement related to compliance and trading restrictions prior to earnings disclosure. Given the short length (1906 characters) and the nature of the content, this fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and compliance documents that do not fit other categories.
2025-09-26 English
Price movement
Regulatory Filings Classification · 100% confidence The document is a letter addressed to stock exchanges responding to an inquiry about significant price movement of the company's security. It references compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, which pertains to disclosure of price sensitive information. The letter clarifies that the company is not aware of any unpublished price sensitive information and that the price movement is market driven. The document is a regulatory communication clarifying a market event rather than a financial report, audit, or management discussion. It is short (2042 characters) and serves as a regulatory filing to comply with stock exchange requirements. Therefore, it fits best under Regulatory Filings (RNS).
2025-09-23 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a communication addressed to stock exchanges regarding a campaign initiated by the Investor Education and Protection Fund Authority to encourage shareholders to claim unpaid or unclaimed dividends. It includes instructions for shareholders to update their KYC and other details to prevent transfer of dividends to the IEPF. The document is dated and signed by the Managing Director and contains no financial statements, earnings data, or detailed financial analysis. It is an announcement related to shareholder engagement and regulatory compliance rather than a financial report or detailed filing. The content fits best under a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit into other specific categories such as Dividend Notice or Annual Report. The document length is moderate but the content is clearly an announcement and not a report itself.
2025-08-21 English
Credit Rating
Capital/Financing Update Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding a credit rating revision by ICRA Limited for various financial instruments of Natural Capsules Limited. It includes detailed rating changes, previous and current ratings, and explanations from the rating agency. The content focuses on credit rating updates and related disclosures under SEBI regulations. There are no financial statements, earnings data, or management discussions typical of annual or interim reports. The document is not a report itself but an official announcement of a credit rating update, which falls under capital/financing activities. Therefore, the document is best classified as a Capital/Financing Update (CAP). The document length (7963 characters) supports it being a full announcement rather than a brief notice or certification.
2025-08-13 English
Copy of Newspaper Publication
Regulatory Filings
2025-08-07 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.